Met Life Investment Management, LLC Neoleukin Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$4.65 - $7.75 $20,292 - $33,821
-4,364 Closed
0 $0
Q3 2021

May 17, 2024
SELL
$6.05 - $9.66 $61,637 - $98,416
-10,188 Reduced 70.01%
4,364 $31,000
Q3 2021

Jun 21, 2023
BUY
$6.05 - $9.66 $26,402 - $42,156
4,364 New
4,364 $31,000
Q3 2021

Mar 22, 2023
SELL
$6.05 - $9.66 $61,637 - $98,416
-10,188 Reduced 70.01%
4,364 $31,000
Q3 2021

Nov 15, 2021
SELL
$6.05 - $9.66 $61,637 - $98,416
-10,188 Reduced 70.01%
4,364 $32,000
Q2 2021

May 17, 2024
BUY
$9.23 - $13.12 $99,093 - $140,856
10,736 Added 281.34%
14,552 $134,000
Q2 2021

Jun 21, 2023
BUY
$9.23 - $13.12 $134,314 - $190,922
14,552 New
14,552 $134,000
Q2 2021

Mar 22, 2023
BUY
$9.23 - $13.12 $99,093 - $140,856
10,736 Added 281.34%
14,552 $134,000
Q2 2021

Aug 16, 2021
BUY
$9.23 - $13.12 $99,093 - $140,856
10,736 Added 281.34%
14,552 $134,000
Q1 2021

May 17, 2024
BUY
$11.26 - $15.78 $42,968 - $60,216
3,816 New
3,816 $46,000
Q1 2021

Jun 26, 2023
BUY
$11.26 - $15.78 $42,968 - $60,216
3,816 New
3,816 $47 Million
Q1 2021

Mar 22, 2023
SELL
$11.26 - $15.78 $123,465 - $173,027
-10,965 Reduced 74.18%
3,816 $46,000
Q1 2021

May 14, 2021
SELL
$11.26 - $15.78 $123,465 - $173,027
-10,965 Reduced 74.18%
3,816 $47,000
Q4 2020

Jun 22, 2023
BUY
$10.17 - $14.56 $150,322 - $215,211
14,781 New
14,781 $208,000
Q3 2020

Jun 26, 2023
BUY
$9.68 - $17.01 $143,080 - $251,424
14,781 New
14,781 $177,000
Q2 2020

May 24, 2024
BUY
$9.95 - $17.05 $147,070 - $252,016
14,781 New
14,781 $245 Million
Q2 2020

Jun 26, 2023
BUY
$9.95 - $17.05 $147,070 - $252,016
14,781 New
14,781 $245,000
Q2 2020

Mar 22, 2023
BUY
$9.95 - $17.05 $147,070 - $252,016
14,781 New
14,781 $245,000
Q2 2020

Aug 14, 2020
BUY
$9.95 - $17.05 $147,070 - $252,016
14,781 New
14,781 $245,000

Others Institutions Holding NLTX

# of Institutions
1
Shares Held
199K
Call Options Held
0
Put Options Held
0
View Full List

About Neoleukin Therapeutics, Inc.

NLTX Quotes by TradingView
  • Ticker NLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,579,900
  • Description
  • Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...
More about NLTX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email